Show simple item record

2024-02-03Zeitschriftenartikel
Measles vaccination – An underestimated prevention measure: Analyzing a fatal case in Hildesheim, Germany
dc.contributor.authorHueppe, Katharina
dc.contributor.authorOrtman, Jan
dc.contributor.authorGauselmann, Hannah
dc.contributor.authorSantibanez, Sabine
dc.contributor.authorMankertz, Annette
dc.date.accessioned2026-02-10T13:06:24Z
dc.date.available2026-02-10T13:06:24Z
dc.date.issued2024-02-03none
dc.identifier.other10.1016/j.ijmm.2024.151608
dc.identifier.urihttp://edoc.rki.de/176904/13313
dc.description.abstractMeasles and rubella are targeted for elimination in the WHO region Europe. To reach the elimination goal, vaccination coverage of 95% must be achieved and sustained, the genotype information has to be provided for 80% of all outbreaks and transmission chains of a certain variant must not be detected for >12 months. The latter information is collected at Germany’s National Reference Center Measles, Mumps, Rubella (NRC MMR). We describe here an outbreak of measles occurring in Hildesheim. The outbreak comprised 43 cases and lasted 14 weeks. Surprisingly, a high number of vaccination failures was observed since 11 cases had received two doses of the MMR vaccine and 4 additional cases were vaccinated once. A 33-year-old woman passed away during the outbreak. She was the mother of 5 children between 4 and 16 years of age. Two schoolchildren contracted measles and passed it on to the rest of the family. Due to delivery bottlenecks, the vaccination of the mother was delayed. She developed measles-like symptoms 3 days after vaccination and was found dead on the morning of day 8 after vaccination. A post-mortem examination was done to identify the cause of death. Moreover, molecular characterization of the virus was performed to analyze whether she was infected by the wildtype virus circulating at that time in Hildesheim or whether the vaccine may have been a concomitant and aggravating feature of her death. The result showed that the samples taken from her at the time of death and during necropsy contained the wildtype measles virus variant corresponding to MVs/Gir Somnath.IND/42.16 (WHO Seq-ID D8–4683) that fueled the Hildesheim outbreak and circulated in Germany from March 2018 to March 2020. The vaccine virus was not detected. Moreover, two aspects uncovered by the post-mortem examination were remarkable; the woman died from giant cell pneumonia, which is a complication seen in immune-suppressed individuals and she was actively using cannabis. THC is known to influence the immune system, but literature reports describing the effects are limited.eng
dc.language.isoengnone
dc.publisherRobert Koch-Institut
dc.rights(CC BY 3.0 DE) Namensnennung 3.0 Deutschlandger
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/de/
dc.subjectMeasleseng
dc.subjectVaccine preventable diseaseeng
dc.subjectOutbreakeng
dc.subjectGiant cell pneumoniaeng
dc.subjectEliminationeng
dc.subjectGenotypingeng
dc.subjectTHCeng
dc.subjectPost-mortem examinationeng
dc.subject.ddc610 Medizin und Gesundheitnone
dc.titleMeasles vaccination – An underestimated prevention measure: Analyzing a fatal case in Hildesheim, Germanynone
dc.typearticle
dc.identifier.urnurn:nbn:de:0257-176904/13313-0
dc.type.versionpublishedVersionnone
local.edoc.container-titleInternational Journal of Medical Microbiologynone
local.edoc.type-nameZeitschriftenartikel
local.edoc.container-typeperiodical
local.edoc.container-type-nameZeitschrift
local.edoc.container-publisher-nameElsevier B.V.none
local.edoc.container-reportyear2024none
local.edoc.container-firstpage1none
local.edoc.container-lastpage6none
dc.description.versionPeer Reviewednone

Show simple item record